Wave Life Sciences (WVE): A Valuation Deep Dive Following Pipeline Progress and Investor Optimism [Yahoo! Finance]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Yahoo! Finance
Optimism is building around new clinical programs, particularly with progress in several disease areas. See our latest analysis for Wave Life Sciences. Even after today's sharp 11.4% share price rally, Wave Life Sciences remains well below where it started the year. However, long-term holders have seen a 79% total return over three years. Recent momentum seems fueled by growing confidence in its technology and pipeline, with investors betting that anticipated clinical milestones could significantly shift the company's prospects. If this kind of biotech momentum has you curious about what else could be next, it's a great moment to discover See the full list for free. Yet with shares rallying so sharply, investors are left to debate whether Wave Life Sciences is still trading at a discount or if the recent surge has already factored in the potential of its clinical pipeline. Could there still be upside for new buyers? Most Popular Narrative: 59.6% Undervalued With Wave Life
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- Wave Life Sciences: Being Realistic, There Is Still So Much To Prove [Seeking Alpha]Seeking Alpha
- Arrowhead Pharmaceuticals: Important Catalysts And Some Challenges Ahead [Seeking Alpha]Seeking Alpha
- Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning [Yahoo! Finance]Yahoo! Finance
- WAVE Life Sciences Ltd (WVE) Q3 2025 Earnings Call Highlights: Promising Clinical Advances and ... [Yahoo! Finance]Yahoo! Finance
- WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Wedbush from $18.00 to $20.00. They now have an "outperform" rating on the stock.MarketBeat
WVE
Earnings
- 11/10/25 - Miss
WVE
Sec Filings
- 11/17/25 - Form 8-K
- 11/14/25 - Form 4
- 11/14/25 - Form 4
- WVE's page on the SEC website